伊芙美爾醫療 ICCC 深 滬
等待開盤 12-16 09:30:00 美东时间
6.06
-0.150
-2.42%
華盛通- 最 高6.24
- 今 開6.24
- 成交量 1009股
- 最 低 6.06
- 昨 收 6.21
- 總市值 5481.82万
- 52周最高 7.60
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 4.28
- 委 比 -51.90%
- 總股本 904.59万
- 歷史最高 13.20
- 量 比 0.06
- 振 幅 2.90%
- 歷史最低 3.19
- 每 手 1
- 風險率 0.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
ImmuCell Corporation (Nasdaq: ICCC) plans to release its unaudited Q3 2025 financial results after market close on November 13, 2025. A conference call to discuss the results is scheduled for November 14, 2025 at 9:00 AM ET. Participants can join by dialing (844) 855-9502 (toll-free) or (412) 317-5499 (international). A replay will be available until November 21, 2025 at (877) 344-7529 (toll-free) or (412) 317-0088 (international) using replay co...
11-06 21:05
ImmuCell Announces New CEO and Leadership Changes
The latest update is out from Immucell ( ($ICCC) ). ImmuCell Corporation announ...
11-05 05:45
mmuCell appoints Olivier te Boekhorst as new CEO
ImmuCell (NASDAQ:ICCC) announced on Tuesday that Olivier te Boekhorst will serve as President and CEO of the company effective November 1, 2025. The company’s Board of directors appointed te Boekhorst...
11-05 05:28
ImmuCell announces preliminary sales results for Q3
ImmuCell Corporation (NASDAQ:ICCC) announced on Tuesday preliminary, unaudited sales results for the third quarter of 2025. Preliminary, Unaudited Total Sales Results: 2025 2024 ($ Decrease) $ I...
10-08 04:13
ImmuCell Announces Preliminary Q3 2025 Revenue Of $5.5M
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and
10-08 04:09
ImmuCell appoints Olivier te Boekhorst as CEO
ImmuCell (NASDAQ:ICCC) announced that it has selected Olivier te Boekhorst as its next President and CEO, anticipating a start date of November 1, 2025. The company said te Boekhorst is currently an o...
09-30 04:13
ImmuCell Selects Olivier Te Boekhorst As Its Next President, CEO, Expected Start Date November 1, 2025
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven
09-30 04:06
ImmuCell Announces Selection of its Next President and CEO
ImmuCell Corporation announced the appointment of Olivier te Boekhorst as its new President and CEO, effective November 1, 2025. te Boekhorst, currently an Operating Partner at ARCHIMED and former CEO of SeqCenter, previously held leadership roles at IDEXX Laboratories, where he oversaw M&A activities and business growth. The Company’s current CEO, Michael F. Brigham, will serve as Special Advisor for two months to ensure a smooth transition. Imm...
09-29 20:05
【爱建电子】电子行业周报：Amazfit产业链迎来业绩拐点
（来源：爱建证券研究所） Amazfit产业链迎来业绩拐点 -爱建电子行业周报- 本报告发布于2025年08月20日 投资要点： 被动元件...
08-20 17:58
